UNITED THERAPEUTICS Corp Insider Trading for October 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in UNITED THERAPEUTICS Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in UNITED THERAPEUTICS Corp for October 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 31 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 30.75 | 5,547 | 170,570 | 626,776 | |
Oct 31 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 34.56 | 4,115 | 142,214 | 226,340 | |
Oct 31 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 131.82 | 100 | 13,182 | 140 | 240 to 140 (-41.67 %) |
Oct 31 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 130.71 | 2,250 | 294,090 | 240 | 2.5 K to 240 (-90.36 %) |
Oct 31 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 130.26 | 3,197 | 416,427 | 2,490 | 5.7 K to 2.5 K (-56.22 %) |
Oct 31 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 30.75 | 5,547 | 170,570 | 5,687 | 140 to 5.7 K (+3,962.14 %) |
Oct 31 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 130.36 | 4,115 | 536,417 | 140 | 4.3 K to 140 (-96.71 %) |
Oct 31 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 34.56 | 4,115 | 142,214 | 4,255 | 140 to 4.3 K (+2,939.29 %) |
Oct 30 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 63.22 | 2,211 | 139,779 | 479,806 | |
Oct 30 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 132.43 | 500 | 66,215 | 140 | 640 to 140 (-78.12 %) |
Oct 30 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 131.19 | 500 | 65,595 | 640 | 1.1 K to 640 (-43.86 %) |
Oct 30 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 130.51 | 1,211 | 158,048 | 1,140 | 2.4 K to 1.1 K (-51.51 %) |
Oct 30 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 63.22 | 2,211 | 139,779 | 2,351 | 140 to 2.4 K (+1,579.29 %) |
Oct 29 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 52.65 | 2,592 | 136,469 | 565,028 | |
Oct 29 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 133.00 | 30 | 3,990 | 140 | 170 to 140 (-17.65 %) |
Oct 29 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 131.81 | 1,100 | 144,995 | 170 | 1.3 K to 170 (-86.61 %) |
Oct 29 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 132.40 | 1,462 | 193,564 | 1,270 | 2.7 K to 1.3 K (-53.51 %) |
Oct 29 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 52.65 | 2,592 | 136,469 | 2,732 | 140 to 2.7 K (+1,851.43 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 30.75 | 5,547 | 170,570 | 632,323 | |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 34.56 | 4,115 | 142,214 | 230,455 | |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 63.22 | 2,211 | 139,779 | 482,017 | |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 131.32 | 800 | 105,054 | 140 | 940 to 140 (-85.11 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 130.41 | 1,300 | 169,526 | 940 | 2.2 K to 940 (-58.04 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 129.32 | 1,400 | 181,044 | 2,240 | 3.6 K to 2.2 K (-38.46 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 128.51 | 2,047 | 263,053 | 3,640 | 5.7 K to 3.6 K (-35.99 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 30.75 | 5,547 | 170,570 | 5,687 | 140 to 5.7 K (+3,962.14 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 131.53 | 1,965 | 258,452 | 140 | 2.1 K to 140 (-93.35 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 130.66 | 2,150 | 280,908 | 2,105 | 4.3 K to 2.1 K (-50.53 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 34.56 | 4,115 | 142,214 | 4,255 | 140 to 4.3 K (+2,939.29 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 130.54 | 100 | 13,054 | 140 | 240 to 140 (-41.67 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 128.91 | 111 | 14,309 | 240 | 351 to 240 (-31.62 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 129.80 | 1,000 | 129,800 | 351 | 1.4 K to 351 (-74.02 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 127.91 | 1,000 | 127,910 | 1,351 | 2.4 K to 1.4 K (-42.54 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 63.22 | 2,211 | 139,779 | 2,351 | 140 to 2.4 K (+1,579.29 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Option Exercise | M | 30.75 | 5,000 | 153,750 | 19,750 | |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Option Exercise | M | 33.14 | 6,000 | 198,840 | 94,750 | |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | S | 131.16 | 1,276 | 167,358 | 34,832 | 36.1 K to 34.8 K (-3.53 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | S | 130.20 | 2,566 | 334,094 | 36,108 | 38.7 K to 36.1 K (-6.63 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | S | 129.29 | 1,158 | 149,712 | 38,674 | 39.8 K to 38.7 K (-2.91 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Buy | M | 30.75 | 5,000 | 153,750 | 39,832 | 34.8 K to 39.8 K (+14.35 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | S | 124.38 | 6,000 | 746,280 | 34,832 | 40.8 K to 34.8 K (-14.69 %) |
Oct 23 2014 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Buy | M | 33.14 | 6,000 | 198,840 | 40,832 | 34.8 K to 40.8 K (+17.23 %) |
Oct 21 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 52.65 | 2,592 | 136,469 | 567,620 | |
Oct 21 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 126.22 | 430 | 54,275 | 140 | 570 to 140 (-75.44 %) |
Oct 21 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 125.39 | 662 | 83,008 | 570 | 1.2 K to 570 (-53.73 %) |
Oct 21 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 124.19 | 1,500 | 186,285 | 1,232 | 2.7 K to 1.2 K (-54.90 %) |
Oct 21 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 52.65 | 2,592 | 136,469 | 2,732 | 140 to 2.7 K (+1,851.43 %) |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & COO | Option Exercise | M | 30.75 | 10,000 | 307,500 | 30,000 | |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & COO | Sell | S | 124.85 | 10,000 | 1,248,478 | 1,234 | 11.2 K to 1.2 K (-89.02 %) |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & COO | Buy | M | 30.75 | 10,000 | 307,500 | 11,234 | 1.2 K to 11.2 K (+810.37 %) |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | Ferrari John Maxim | CFO | Option Exercise | M | 50.09 | 10,000 | 500,900 | 0 | |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | Ferrari John Maxim | CFO | Sell | S | 124.38 | 10,000 | 1,243,800 | 407 | 10.4 K to 407 (-96.09 %) |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | Ferrari John Maxim | CFO | Buy | M | 50.09 | 10,000 | 500,900 | 10,407 | 407 to 10.4 K (+2,457.00 %) |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 30.75 | 5,547 | 170,570 | 637,870 | |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 34.56 | 4,115 | 142,214 | 234,570 | |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 125.26 | 564 | 70,648 | 140 | 704 to 140 (-80.11 %) |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 124.62 | 1,483 | 184,804 | 704 | 2.2 K to 704 (-67.81 %) |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 123.35 | 1,200 | 148,018 | 2,187 | 3.4 K to 2.2 K (-35.43 %) |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 122.57 | 800 | 98,053 | 3,387 | 4.2 K to 3.4 K (-19.11 %) |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 121.49 | 700 | 85,046 | 4,187 | 4.9 K to 4.2 K (-14.32 %) |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 120.58 | 800 | 96,467 | 4,887 | 5.7 K to 4.9 K (-14.07 %) |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 30.75 | 5,547 | 170,570 | 5,687 | 140 to 5.7 K (+3,962.14 %) |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 121.50 | 800 | 97,200 | 140 | 940 to 140 (-85.11 %) |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 120.82 | 3,315 | 400,501 | 940 | 4.3 K to 940 (-77.91 %) |
Oct 17 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 34.56 | 4,115 | 142,214 | 4,255 | 140 to 4.3 K (+2,939.29 %) |
Oct 16 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 63.22 | 2,211 | 139,779 | 484,228 | |
Oct 16 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 120.08 | 2,211 | 265,497 | 140 | 2.4 K to 140 (-94.05 %) |
Oct 16 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 63.22 | 2,211 | 139,779 | 2,351 | 140 to 2.4 K (+1,579.29 %) |
Oct 14 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 52.65 | 2,592 | 136,469 | 570,212 | |
Oct 14 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 126.09 | 1,100 | 138,699 | 140 | 1.2 K to 140 (-88.71 %) |
Oct 14 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 123.44 | 800 | 98,752 | 1,240 | 2 K to 1.2 K (-39.22 %) |
Oct 14 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 122.50 | 692 | 84,770 | 2,040 | 2.7 K to 2 K (-25.33 %) |
Oct 14 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 52.65 | 2,592 | 136,469 | 2,732 | 140 to 2.7 K (+1,851.43 %) |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 30.75 | 5,547 | 170,570 | 643,417 | |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 34.56 | 4,115 | 142,214 | 238,685 | |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 131.40 | 700 | 91,978 | 140 | 840 to 140 (-83.33 %) |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 130.58 | 1,600 | 208,927 | 840 | 2.4 K to 840 (-65.57 %) |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 129.50 | 704 | 91,165 | 2,440 | 3.1 K to 2.4 K (-22.39 %) |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 128.44 | 2,543 | 326,631 | 3,144 | 5.7 K to 3.1 K (-44.72 %) |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 30.75 | 5,547 | 170,570 | 5,687 | 140 to 5.7 K (+3,962.14 %) |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 130.51 | 4,115 | 537,056 | 140 | 4.3 K to 140 (-96.71 %) |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 34.56 | 4,115 | 142,214 | 4,255 | 140 to 4.3 K (+2,939.29 %) |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Option Exercise | M | 30.75 | 5,000 | 153,750 | 24,750 | |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | S | 131.58 | 300 | 39,473 | 34,832 | 35.1 K to 34.8 K (-0.85 %) |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | S | 131.06 | 2,814 | 368,810 | 35,132 | 37.9 K to 35.1 K (-7.42 %) |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | S | 129.95 | 1,507 | 195,831 | 37,946 | 39.5 K to 37.9 K (-3.82 %) |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | S | 128.85 | 379 | 48,834 | 39,453 | 39.8 K to 39.5 K (-0.95 %) |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Buy | M | 30.75 | 5,000 | 153,750 | 39,832 | 34.8 K to 39.8 K (+14.35 %) |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 63.22 | 2,211 | 139,779 | 486,439 | |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 132.23 | 700 | 92,561 | 140 | 840 to 140 (-83.33 %) |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 131.49 | 1,011 | 132,936 | 840 | 1.9 K to 840 (-54.62 %) |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 130.52 | 500 | 65,260 | 1,851 | 2.4 K to 1.9 K (-21.27 %) |
Oct 09 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 63.22 | 2,211 | 139,779 | 2,351 | 140 to 2.4 K (+1,579.29 %) |
Oct 07 2014 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & COO | Option Exercise | M | 33.14 | 35,000 | 1,159,900 | 0 | |
Oct 07 2014 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & COO | Sell | S | 130.14 | 35,000 | 4,554,900 | 1,234 | 36.2 K to 1.2 K (-96.59 %) |
Oct 07 2014 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & COO | Buy | M | 33.14 | 35,000 | 1,159,900 | 36,234 | 1.2 K to 36.2 K (+2,836.30 %) |
Oct 07 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 52.65 | 2,592 | 136,469 | 572,804 | |
Oct 07 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 129.30 | 917 | 118,568 | 140 | 1.1 K to 140 (-86.75 %) |
Oct 07 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 130.04 | 683 | 88,817 | 1,057 | 1.7 K to 1.1 K (-39.25 %) |
Oct 07 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 128.84 | 992 | 127,809 | 1,740 | 2.7 K to 1.7 K (-36.31 %) |
Oct 07 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 52.65 | 2,592 | 136,469 | 2,732 | 140 to 2.7 K (+1,851.43 %) |
Oct 07 2014 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & COO | Option Exercise | M | 30.75 | 10,000 | 307,500 | 40,000 | |
Oct 07 2014 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & COO | Sell | S | 129.79 | 10,000 | 1,297,917 | 1,234 | 11.2 K to 1.2 K (-89.02 %) |
Oct 07 2014 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & COO | Buy | M | 30.75 | 10,000 | 307,500 | 11,234 | 1.2 K to 11.2 K (+810.37 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 30.75 | 5,547 | 170,570 | 648,964 | |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 34.56 | 4,115 | 142,214 | 242,800 | |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 131.57 | 100 | 13,157 | 140 | 240 to 140 (-41.67 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 130.22 | 247 | 32,164 | 240 | 487 to 240 (-50.72 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 129.56 | 2,000 | 259,111 | 487 | 2.5 K to 487 (-80.42 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 128.52 | 600 | 77,112 | 2,487 | 3.1 K to 2.5 K (-19.44 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 127.42 | 1,300 | 165,646 | 3,087 | 4.4 K to 3.1 K (-29.63 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 126.70 | 1,300 | 164,710 | 4,387 | 5.7 K to 4.4 K (-22.86 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 30.75 | 5,547 | 170,570 | 5,687 | 140 to 5.7 K (+3,962.14 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 126.89 | 4,115 | 522,149 | 140 | 4.3 K to 140 (-96.71 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 34.56 | 4,115 | 142,214 | 4,255 | 140 to 4.3 K (+2,939.29 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | DWEK RAYMOND | Director | Option Exercise | M | 30.75 | 3,000 | 92,250 | 0 | |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | DWEK RAYMOND | Director | Sell | S | 131.10 | 3,000 | 393,292 | 0 | 3 K to 0 (-100.00 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | DWEK RAYMOND | Director | Buy | M | 30.75 | 3,000 | 92,250 | 3,000 | 0 to 3 K |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Option Exercise | M | 41.14 | 1,500 | 61,710 | 22,500 | |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Sell | S | 130.65 | 1,500 | 195,976 | 733 | 2.2 K to 733 (-67.17 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Buy | M | 41.14 | 1,500 | 61,710 | 2,233 | 733 to 2.2 K (+204.64 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | Ferrari John Maxim | CFO | Option Exercise | M | 50.09 | 10,000 | 500,900 | 10,000 | |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | Ferrari John Maxim | CFO | Sell | S | 129.46 | 10,000 | 1,294,600 | 407 | 10.4 K to 407 (-96.09 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | Ferrari John Maxim | CFO | Buy | M | 50.09 | 10,000 | 500,900 | 10,407 | 407 to 10.4 K (+2,457.00 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Option Exercise | M | 33.14 | 6,000 | 198,840 | 100,750 | |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | S | 129.46 | 6,000 | 776,760 | 34,832 | 40.8 K to 34.8 K (-14.69 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Buy | M | 33.14 | 6,000 | 198,840 | 40,832 | 34.8 K to 40.8 K (+17.23 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Option Exercise | M | 63.22 | 2,211 | 139,779 | 488,650 | |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 128.68 | 496 | 63,825 | 140 | 636 to 140 (-77.99 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Sell | S | 127.03 | 1,715 | 217,856 | 636 | 2.4 K to 636 (-72.95 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | CEO | Buy | M | 63.22 | 2,211 | 139,779 | 2,351 | 140 to 2.4 K (+1,579.29 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & COO | Option Exercise | M | 33.14 | 20,000 | 662,800 | 35,000 | |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & COO | Sell | S | 128.65 | 20,000 | 2,573,000 | 1,234 | 21.2 K to 1.2 K (-94.19 %) |
Oct 02 2014 | UTHR | UNITED THERAPEUTIC ... | JEFFS ROGER | President & COO | Buy | M | 33.14 | 20,000 | 662,800 | 21,234 | 1.2 K to 21.2 K (+1,620.75 %) |